About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Pancreatic Cancer Clinical Trials | 4,767 Studies Recruiting

Clinical TrialsPancreatic Cancer

Pancreatic Cancer Clinical Trials

Browse 4,767 clinical trials for pancreatic cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 4361-4380 of 4,767 trials

CompletedGhrelin Levels in Pancreatic Cancer PatientsThe primary outcome measure for this study is plasma ghrelin level.NCT00225745·Lebanon, New Hampshire CompletedFOLFIRINOX Plus PF-04136309 in Patients With Borderline Resectable and Locally Advanced Pancreatic AdenocarcinomaThis phase I trial studies the side effects and optimal dose of PF-04136309 when given with combination chemotherapy (FOLFIRINOX; 5-fluorouracil, leucovorin, irinotecan…NCT01413022·St Louis, Missouri Not yet recruitingA Phase 1 Trial Of Safety And Initial Efficacy Of Vagal Nerve Blockade For Cancer-Induced Cachexia In Patients With Metastatic Pancreatic AdenocarcinomaThe goal of this clinical research study is to learn about the safety and tolerability of the OnVagus device when used by patients who have metastatic pancreatic cancer and are…NCT07700212·Houston, Texas UnknownPatientSpot Formerly Known as ArthritisPowerPatient Power is a patient research network and database (registry) to collect prospective information about demographics, self-reported diagnoses and medications, and willingness…NCT03840928·Upper Nyack, New York

Related Searches

pancreas cancertrials

Data from ClinicalTrials.govTerms

UnknownRehabilitation Strategies Following Oesophagogastric and Hepatopancreaticobiliary CancerThe RESTORE II randomized controlled trial will examine the efficacy of a 12 week multidisciplinary rehabilitation program consisting of supervised and home-based exercise,1:1…NCT03958019·Dublin, Leinster

WithdrawnIntegrating Palliative Care and Modern Palliative Care Tools Into the Care of Patients With Pancreas CancerThe main purpose of this study is to evaluate the acceptance by patients with metastatic pancreas cancer of integrating palliative care with usual cancer treatment.NCT01784081·Baltimore, Maryland

CompletedBevacizumab, Gemcitabine, and Oxaliplatin in Treating Patients With Metastatic Pancreatic CancerRATIONALE: Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread.NCT00112528·Mobile, Alabama and 200 others

RecruitingSafety and Efficacy of NRT6008 in Patients With Unresectable Locally Advanced Pancreatic Cancer (LAPC) and Advanced Pancreatic Cancer With Lymph Node MetastasesThis is a single arm, open label, multi-center phase I study, including phase Ia dose escalation and phase Ib dose expansion.NCT06278454·Zhengzhou, Henan and 5 others

CompletedIncentive Spirometry and Upper Abdominal Laparoscopic SurgeryTo compare the effects of volume-oriented versus flow-oriented incentive spirometry on pulmonary function tests and functional capacity in patients of upper abdominal laparoscopic…NCT04716166·Rawalpindi, Punjab Province

CompletedCombination of Anti-PD-1 Antibody and Chemotherapy in Metastatic Pancreatic CancerThe prognosis of pancreatic cancer is extremely poor. NCCN guidelines recommend FOLFIRINOX or modified-FOLFIRINOX as the first-line chemotherapeutic regimen.NCT03977272·Hangzhou, Zhejiang

TerminatedSafety and Effectiveness of ABM-168 in Adults with Advanced Solid Tumors.This is a Phase 1, First-in-Human (FIH), open-label, multicenter, dose escalation and dose expansion study to evaluate the safety, tolerability, pharmacokinetics and preliminary…NCT05831995·San Francisco, California and 5 others

CompletedInterobserver Agreement of Endoscopic Ultrasonography and Endoscopic Sonoelastography in the Evaluation of Lymph NodesEndoscopic ultrasound (EUS) is an important part of the pre-treatment evaluation of patients with upper gastrointestinal tract cancer (esophageal, gastric, pancreatic and liver…NCT01033695·Odense

CompletedStudy to Compare Cardiovascular Side Effects of Teysuno Versus CapecitabineCapecitabine is a chemotherapy drug used to treat many types of cancer including bowel and stomach cancer.NCT01845337·Edinburgh, Scotland

CompletedLEE011 for Patients With CDK4/6 Pathway Activated Tumors (SIGNATURE)The purpose of this signal seeking study was to determine whether treatment with LEE011 demonstrates sufficient efficacy in CDK4/6 pathway activated solid tumors and/or…NCT02187783·Birmingham, Alabama and 60 others

TerminatedAPG-1387 Plus Chemotherapy in Advanced Pancreatic AdenocarcinomaThis study is a two stage study consisting of a dose escalation phase Ib and a phase II study which include subjects with previously-treated, advanced pancreatic adenocarcinoma.NCT04643405·Shanghai, Shanghai Municipality

CompletedUsefulness of Smartphone Application for Improving Nutritional Status of Pancreatic Cancer PatientsMalnutrition of hospitalized patients is reported in the range of 20-60% according to the definition and assessment method of malnutrition.NCT04109495·Seoul

CompletedRobotic vs Laparoscopic and Open Surgery for Abdominopelvic CancersRobotic surgery has become an increasingly common option for treating cancers in the abdomen and pelvis.NCT07821775·Seoul, Songpa-gu

CompletedDalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer PatientsThe goal of this clinical research study is to learn if dalteparin can lower the risk of VTE occurring in the legs and lungs.NCT00966277·Houston, Texas

TerminatedTAS-102 (Lonsurf) in Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma Post First Line Chemotherapy (UF-STO-PANC-003)This is an open-label, non-randomized, sequentially enrolling single arm phase II trial to evaluate the activity of TAS-102 in previously treated metastatic and locally advanced…NCT02921737·Gainesville, Florida and 2 others

CompletedPancreatic Cancer Dietary Assessment StudyThis is a prospective observational study which aims to evaluate; The prevalence of pancreatic insufficiency in patients with pancreatic malignancies (adenocarcinoma and…NCT03616431·Manchester

PreviousPage 219 of 239Next